Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
GRI Bio, Inc. (GRI) had Stock-Based Compensation of $0.26M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.89M |
|
-- |
|
-- |
|
$2.90M |
|
$-2.90M |
|
$0.01M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-2.90M |
|
$-2.90M |
|
2.21M |
|
2.21M |
|
$-1.31 |
|
$-1.31 |
|
| Balance Sheet Financials | |
$5.58M |
|
$0.00M |
|
$0.10M |
|
$5.67M |
|
$2.31M |
|
-- |
|
$0.04M |
|
$2.35M |
|
$3.32M |
|
$3.32M |
|
$3.32M |
|
2.50M |
|
| Cash Flow Statement Financials | |
$-4.90M |
|
-- |
|
$5.00M |
|
$5.03M |
|
$5.12M |
|
$0.09M |
|
|
Stock-Based Compensation |
$0.26M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-87.06% |
|
-87.06% |
|
-50.96% |
|
-87.06% |
|
$1.33 |
|
$-2.22 |
|
$-2.22 |
|